We propose to demonstrate the feasibility of encoding pharmaceutical tablets using UV laser marking technology and edible integral lens array imagery as an anti-counterfeit device where individual tablets can each be uniquely coded with a hologram-like marker with a matching, non-edible, hologram-like marker placed on the outside of the bottle or as a security seal around the cap. Materials to be considered for the edible lens array are listed on the FDA's generally recognized as safe (GRAS) inventory. The integral lens array provides a means to read the markings but cannot readily be used to alter the markings. This provides traceability as well as security analogous to public key encryption. In addition to the benefit to public safety, such capability could be used by the FDA as a standardized method for pharmaceutical inventory.

Public Health Relevance

The successful demonstration of the feasibility of the pharmaceutical laser marking method proposed here will, on further development, provide a means to fight pharmaceutical counterfeiting and thereby safeguard public health.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43FD003890-01A1
Application #
8201055
Study Section
Special Emphasis Panel (ZRG1-IMST-A (12))
Project Start
2011-09-19
Project End
2012-03-31
Budget Start
2011-09-19
Budget End
2012-03-31
Support Year
1
Fiscal Year
2011
Total Cost
Indirect Cost
Name
Boulder Nonlinear Systems, Inc.
Department
Type
DUNS #
602673188
City
Lafayette
State
CO
Country
United States
Zip Code
80026